COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 115 filers reported holding COGENT BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 1.86 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,887,961 | -14.2% | 193,637 | +4.2% | 0.35% | -9.2% |
Q2 2023 | $2,199,659 | +12.1% | 185,782 | +2.1% | 0.38% | -10.8% |
Q1 2023 | $1,962,658 | +19.9% | 181,896 | +28.5% | 0.43% | -2.1% |
Q4 2022 | $1,636,688 | -53.7% | 141,582 | -40.2% | 0.44% | -56.6% |
Q3 2022 | $3,532,000 | +35.6% | 236,697 | -18.0% | 1.00% | +4.7% |
Q2 2022 | $2,605,000 | – | 288,750 | – | 0.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |